IP Library Granted Patent US 8,232,057
Granted Patent B2
US 8,232,057 · App. 11/579,483 · Granted Jul 31, 2012

DNA sequences for the detection of and differentiation amongst pathogenic

Assignee: E I du Pont de Nemours and Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,232,057
App. No.
11/579,483
Granted
Jul 31, 2012
Kind
B2
Abstract

Oligonucleotide sequences and methods for specifically detecting and differentiating amongst pathogenic E. coli in a complex sample. The complex sample can be a food sample, water sample, or selectively enriched food matrix. The methods of detection may utilize PCR amplification with, or without, an internal positive control, and appropriate primer pairs. Reagents for performing the methods can be supplied as a kit and/or in tablet form.

Claims (56)

1. A method for detecting the presence of pathogenic E. coli in a sample, the method comprising:

(a) performing PCR amplification of the sample using a primer pair selected from the group consisting of:

(i) SEQ ID NOs:2 and 3,

(ii) SEQ ID NOs:5 and 6,

(iii) SEQ ID NOs:8 and 9,

(iv) SEQ ID NOs:10 and 11,

(v) SEQ ID NOs:13 and 14, and

(vi) SEQ ID NOs:16 and 17,

to produce a PCR amplification result; and

(b) examining the PCR amplification result of step (a) to detect for an amplification product of the primer pair, whereby a positive detection of the amplification product of the primer pair indicates the presence of pathogenic E. coli in the sample.

2. The method of claim 1 , wherein the primer pair is selected from the group consisting of (a)(ii), (a)(iii), and (a)(iv).

3. The method of claim 1 , wherein the primer pair comprises (a)(ii).

4. The method of claim 1 , wherein the primer pair comprises (a)(iii).

5. The method of claim 1 , wherein the primer pair comprises (a)(iv).

6. A method for detecting the presence of pathogenic E. coli in a sample, the method comprising:

(a) performing PCR amplification of the sample using two different primer pairs selected from the group consisting of:

(i) SEQ ID NOs:2 and 3,

(ii) SEQ ID NOs:5 and 6,

(iii) SEQ ID NOs:8 and 9,

(iv) SEQ ID NOs:10 and 11,

(v) SEQ ID NOs:13 and 14, and

(vi) SEQ ID NOs:16 and 17,

to produce a PCR amplification result; and

(b) examining the PCR amplification result of step (a) to detect for amplification products of both of the two different primer pairs, whereby a positive detection of the amplification products of both of the two different primer pairs indicates the presence of pathogenic E. coli in the sample.

7. The method of claim 6 , wherein the two primer pairs comprise (a)(ii) and (a)(iv).

8. The method of claim 6 , wherein the two primer pairs comprise (a)(ii) and (a)(iii).

9. The method of claim 1 or 2 , wherein in step (b) a melting curve analysis is used to detect for amplification product.

10. The method of claim 1 or 2 , further comprising a step of preparing the sample for PCR amplification prior to said step (a).

11. The method of claim 10 , wherein said preparing step comprises at least one of the following processes: (1) bacterial enrichment, (2) separation of bacterial cells from the sample, (3) cell lysis, and (4) total DNA extraction.

12. The method of claim 1 or 2 , wherein the sample comprises a food sample or a water sample.

13. The method of claim 1 or 2 , wherein the sample comprises a selectively enriched food matrix.

14. A primer for use in primer directed amplification for detection of pathogenic E. coli consisting essentially of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, or SEQ ID NO:17.

15. A kit for detection of pathogenic E. coli , comprising:

(a) at least one primer pair selected from the group consisting of:

(i) SEQ ID NOs:2 and 3,

(ii) SEQ ID NOs:5 and 6,

(iii) SEQ ID NOs:8 and 9,

(iv) SEQ ID NOs:10 and 11,

(v) SEQ ID NOs:13 and 14, and

(vi) SEQ ID NOs:16 and 17; and

(b) thermostable DNA polymerase.

16. The kit of claim 15 , wherein component (a) comprises both (a)(ii) and (a)(iv).

17. The kit of claim 15 , wherein component (a) comprises both (a)(ii) and (a)(iii).

18. A replication composition for use in performance of PCR, comprising:

(a) at least one primer pair selected from the group consisting of:

(i) SEQ ID NOs:2 and 3,

(ii) SEQ ID NOs:5 and 6,

(iii) SEQ ID NOs:8 and 9,

(iv) SEQ ID NOs:10 and 11,

(v) SEQ ID NOs:13 and 14, and

(vi) SEQ ID NOs:16 and 17; and

(b) thermostable DNA polymerase.

19. The replication composition of claim 18 , wherein component (a) comprises both (a)(ii) and (a)(iv).

20. The replication composition of claim 18 , wherein component (a) comprises both (a)(ii) and (a)(iii).

21. A tablet comprising the replication composition of claim 18 , 19 , or 20 .

22. A kit for detection of pathogenic E. coli in a sample, comprising the tablet of claim 21 .

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055644/0636 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AT REEL/FRAME NO. 41983/0340 Recorded Mar 16, 2021
From: ANTARES CAPITAL LP, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055628/0366 →
SECURITY INTEREST Recorded Mar 16, 2017
From: QUALICON DIAGNOSTICS LLC, AS THE GRANTOR
To: ARES CAPITAL CORPORATION, AS SECOND LIEN ADMINISTRATIVE AGENT
Reel/Frame 041602/0334 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Mar 13, 2017
From: QUALICON DIAGNOSTICS LLC
To: ANTARES CAPITAL LP, AS FIRST LIEN ADMINISTRATIVE AGENT
Reel/Frame 041983/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2017
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 041468/0214 →
Continuity (1)
Related Publication 20090068647A1 · Mar 12, 2009